Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.
The San Antonio Breast Cancer Symposium is now considered the most important international breast cancer meeting worldwide. On 8-11th December 2004, approximately 6700 participants attended the meeting and shared the latest findings from breast cancer research. All the main fields of breast cancer research and treatment were covered. This report will focus on the most relevant advancements in the pharmacotherapy of breast cancer. The selected presentations have been grouped together in separate sections, including the fields of prevention, early disease and advanced disease. The most promising data from translational research have also been included, with particular regard to those who will most likely influence the management of breast cancer patients in the future.
Ponzone
Riccardo
R
Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment (IRCC), Strada Provinciale 142, 10060 Candiolo, Turin, Italy. rponzone@mauriziano.it
Sismondi
Piero
P
D000077384:Anastrozole; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D016503:Drug Delivery Systems; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D000077267:Fulvestrant; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D009570:Nitriles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D013629:Tamoxifen / Q000627:therapeutic use; D043823:Taxoids / Q000627:therapeutic use; D000068878:Trastuzumab; D014230:Triazoles / Q000627:therapeutic use
D000077384:Anastrozole; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D047072:Aromatase Inhibitors; D004958:Estradiol; D000077267:Fulvestrant; D012739:Gonadal Steroid Hormones; D009570:Nitriles; D018719:Erb-b2 Receptor Tyrosine Kinases; D013629:Tamoxifen; D043823:Taxoids; D000068878:Trastuzumab; D014230:Triazoles